Dogan, M. Et Al. 2011. The relationship between common EGFR, b-raf, k-ras mutations, and prognosis in advanced-stage NSCLC with response to the treatment. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15 .

Dogan, M., Demirkazik, A., Tukun, A., AKBULUT, H., SAK, S., Ceyhan, K., ... Yalcin, B.(2011). The relationship between common EGFR, b-raf, k-ras mutations, and prognosis in advanced-stage NSCLC with response to the treatment. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.

Dogan, M. Et Al. "The relationship between common EGFR, b-raf, k-ras mutations, and prognosis in advanced-stage NSCLC with response to the treatment," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011

Dogan, M. Et Al. "The relationship between common EGFR, b-raf, k-ras mutations, and prognosis in advanced-stage NSCLC with response to the treatment." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011

Dogan, M. Et Al. (2011) . "The relationship between common EGFR, b-raf, k-ras mutations, and prognosis in advanced-stage NSCLC with response to the treatment." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.

@article{article, author={M. Dogan Et Al. }, title={The relationship between common EGFR, b-raf, k-ras mutations, and prognosis in advanced-stage NSCLC with response to the treatment}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}